BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cuestas ML, Oubiña JR, Mathet VL. Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement. World J Pharmacol 2015; 4(1): 96-116 [DOI: 10.5497/wjp.v4.i1.96] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Devan AR, Pavithran K, Nair B, Murali M, Nath LR. Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma. World J Gastroenterol 2022; 28(36): 5250-5264 [DOI: 10.3748/wjg.v28.i36.5250] [Reference Citation Analysis]
2 Sahu T, Mehta A, Verma HK, Bhaskar L. Multidrug resistance, a major obstacle in hepatocellular carcinoma treatment: challenges and future perspectives. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 2022. [DOI: 10.1016/b978-0-323-98807-0.00020-x] [Reference Citation Analysis]